Prehospital management of acute myocardial infarction: Electrocardiogram acquisition and interpretation, and thrombolysis by prehospital care providers

Canadian Journal of Cardiology

Volumn 14, Issue 10, 1998, Pages 1231-1240

  Myers, Robert B H ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Prehospital thrombolysis; ST elevation acute myocardial infarction; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; FIRST AID; HUMAN; META ANALYSIS; MORTALITY; NURSE; PARAMEDICAL PERSONNEL; PATIENT SELECTION; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; URBAN POPULATION;

ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; EMERGENCY MEDICAL TECHNICIANS; EUROPE; FIBRINOLYSIS; FORECASTING; HUMANS; MYOCARDIAL INFARCTION; NORTH AMERICA; RANDOMIZED CONTROLLED TRIALS; RURAL HEALTH; TELEMETRY; THROMBOLYTIC THERAPY; TIME FACTORS; URBAN HEALTH;

EID: 0031757892     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet 1986;i:397-402.
2. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993,342:759-66
3. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaborative Group. Lancet 1993;342:767-72.
4. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of infarct Survival) Collaborative Group. Lancet 1988;ii:349-60.
5. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994,343:311-22.
6. Weaver WD. Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol 1995,25(7 Suppl):3S-9S.
7. Hermens WT, Willems GM, Nijssen KM, Simoons ML. Effect of thrombolytic treatment delay on myocardial infarct size. Lancet 1992;340:1297. (Lett)
8. Sheehan FH, Braunwald E, Canner P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation 1987;75:817-29.
9. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270:1211-6.
10. Maynard C, Althouse R, Olsufka M, Ritchie JL, Davis KB, Kennedy JW. Early versus late hospital arrival for acute myocardial infarction in the western Washington thrombolytic therapy trials. Am J Cardiol 1989;63:1296-300.
11. Trent RJ, Rose EL, Adams JN, Jennings KP, Rawles JM. Delay between the onset of symptoms of acute myocardial infarction and seeking medical assistance is influenced by left ventricular function at presentation. Br Heart J 1995;73:125-8.
12. Weaver WD, Kennedy JW. Myocardial infarction: Thrombolytic therapy in the pre-hospital setting. In: Fuster V, Verstraete M, eds. Thrombosis in Cardiovascular Disorders. Philadelphia: WB Saunders, 1992:275-87.
13. Every NR, Weaver WD. Prehospital treatment of myocardial infarction. Current Probl Cardiol 1995;20:1-50.
14. Barbash GI, Roth A, Hod H, et al. Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction. Am J Cardiol 1990;66:261-6.
15. Schmidt SB, Borsch MA. The prehospital phase of acute myocardial infarction in the era of thrombolysis. Am J Cardiol 1990;65:1411-5.
16. Leizorovicz A, Haugh MC, Mercier C, Boissel J-P. Pre-hospital and hospital time delays in thrombolytic treatment in patients with suspected acute myocardial infarction: Analysis of data from the EMIP study. European Myocardial Infarction Project. Eur Heart J 1997;18:248-53.
17. Gurwitz JH, McLaughlin TJ, Willison DJ, et al. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med 1997;126:593-9.
18. Blohm M, Herlitz J, Hartford M, et al. Consequences of a media campaign focusing on delay in acute myocardial infarction. Am J Cardiol 1992;69:411-3.
19. Ho MT, Eisenberg MS, Litwin PE, Schaeffer SM, Damon SK. Delay between onset of chest pain and seeking medical care: the effect of public education. Ann Emerg Med 1989;18:727-31.
20. Mitic WR, Perkins J. The effect of a media campaign on heart attack delay and decision times. Can J Public Health 1984;75:414-8.
21. Herlitz J, Hartford M, Blohm M, et al. Effect of a media campaign on delay times and ambulance use in suspected acute myocardial infarction. Am J Cardiol 1989;64:90-3.
22. Kereiakes DJ, Weaver WD, Anderson JL, et al. Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J 1990;120:773-80.
23. Bouten MJM, Simoons ML, Hartman JAM, van Miltenburg AJM, van der Does E, Pool J. Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction. Eur Heart J 1992;13:925-31.
24. Aufderheide TP, Keelan MH, Hendley GE, et al. Milwaukee Prehospital Chest Pain Project - phase I: feasibility and accuracy of prehospital thrombolytic candidate selection. Am J Cardiol 1992;69:991-6.
25. Weaver WD, Eisenberg MS, Martin JS, et al. Myocardial Infarction Triage and Intervention Project - phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol 1990;15:925-31.
26. Karagounis L, Ipsen SK, Jessop MR, et al. Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1990;66:786-91.
27. MacCallum AG, Stafford PJ, Jones C, Vincent R, Perez-Avila C, Chamberlain DA. Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J 1990;11(Suppl F):48-52.
28. Foster DB, Dufendach JH, Barkdoll CM, Mitchell BK. Prehospital recognition of AMI using independent nurse/paramedic 12-lead ECG evaluation: impact on in-hospital times to thrombolysis in a rural community hospital. Am J Emerg Med 1994;12:25-31.
29. Brinsfield K, Feldman J, Bernard S, White D, Maceijko T, Mottley JL. Identification of ST elevation AMI on prehospital 12 lead ECG: Accuracy of unaided paramedic interpretation. J Emerg Med 1998;16:22S. (Abst)
30. O'Rourke M, Cook A, Gallagher D, Carroll G, Hall J. Electrocardiographic diagnoses of evolving myocardial infarction without telemetry for paramedic-initiated pre-hospital thrombolysis. J Am Coll Cardiol 1991;17:331A. (Abst)
31. Kudenchuk PJ, Ho MT, Weaver WD, et al. Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy, MITI Project Investigators. J Am Coll Cardiol 1991;17:1486-91.
32. Koren G, Weiss AT, Hasin Y, et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 1985;313:1384-9.
33. Castaigne AD, Duval AM, Dubois-Rande JL, Herve C, Jan F, Louvard Y. Prehospital administration of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Drugs 1987;33(Suppl 3):231-4.
34. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. The European Myocardial Infarction Project Group. N Engl J Med 1993;329:383-9.
35. Castaigne AD, Herve C, Duval-Moulin AM, et al. Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol 1989;64:30A-3A.
36. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT group. BMJ 1992;305:548-53.
37. Bossaert LL, Demey HE, Colemont LJ, et al. Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Crit Care Med 1988;16:823-30.
38. Schofer J, Buttner J, Geng G, et al. Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 1990;66:1429-33.
39. Weiss AT, Fine DG, Applebaum D, et al. Prehospital coronary thrombolysis. A new strategy in acute myocardial infarction. Chest 1987;92:124-8.
40. McAleer B, Ruane B, Burke E, et al. Prehospital thrombolysis in a rural community: short- and long-term survival. Cardiovasc Drugs Ther 1992;6:369-72.
41. Roth A, Barbash GI, Hod H, et al. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol 1990;15:932-6.
42. Very early thrombolytic therapy in suspected acute myocardial infarction. The Thrombolysis Early in Acute Heart Attack Trial Study Group. Am J Cardiol 1990;65:401-7.
43. McNeill AJ, Cunningham SR, Flannery DJ, et al. A double-blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction. Br Heart J 1989;61:316-21.
44. Roberts MJD, McNeill AJ, MacKenzie G, Adgey AAJ. Time delays to lytic therapy and outcome in 100 consecutive patients with a history suggestive of acute myocardial infarction in an area with access to a mobile coronary care unit. Eur Heart J 1994;15:594-601.
45. Rawles J. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1994;23:1-5.
46. Kennedv JW, Weaver WD. Potential use of thrombolytic therapy before hospitalization. Am J Cardiol 1989;64:8A-11A.
47. Linderer T, Schroder R, Arntz R, et al. Prehospital thrombolysis: Beneficial effects of very early treatment on infarct size and left ventricular function. J Am Coll Cardiol 1993;22:1304-10.
48. Grijseels EWM, Bouten MJ, Lenderink T, et al. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients. Eur Heart J 1995;16:1833-8.
49. Rawles J. Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence from Grampian region early anistreplase trial. BMJ 1996;312:212-5.
50. Rawles JM. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1997;30:1181-6.
51. Fath-Ordoubadi F, Al-Mohammad A, Huehns T, Beatt K. Meta-analysis of randomized trials of prehospital versus hospital thrombolysis. Circulation 1994;90:1325. (Abst)
52. Stone GW, Grines CL, Browne KF, et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: The Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1995;25 370-7.
53. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
54. Aufderheide TP, Kereiakes DJ, Weaver WD, Gibler WB, Simoons ML. Planning, implementation, and process monitoring for pre-hospital 12 lead ECG diagnostic programs. Prehosp Disaster Med 1996;11:162-71.
55. Aufderheide TP, Hendley GE, Woo J, Lawrence S, Valley V, Teichman SL. A prospective evaluation of prehospital 12-lead ECG application in chest pain patients. J Electrocardiol 1992;24(Suppl):8-13.
56. Aufderheide TP. Prehospital 12-lead electrocardiography and evaluation of the patient with chest pain. In: Gibier WB, Aufderheide TP, eds. Emergency Cardiac Care. St Louis: Mosby Year-Book, 1994.